2024-11-28 05:43:29
CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline
Corporate/ 2023-07-24
CARsgen 2022 Interim Results: Innovative...

SHANGHAI,Aug. 24,2022--CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for ...

Everest Medicines Announces Interim Results for First Half of 2022
Corporate/ 2023-07-24
Everest Medicines Announces Interim Resu...

SHANGHAI,Aug. 24,2022-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release